Dumont Blake Investment Advisors Lowers stake in Baxter International Inc (BAX)

Baxter International Inc (BAX) : Dumont Blake Investment Advisors reduced its stake in Baxter International Inc by 8.31% during the most recent quarter end. The investment management company now holds a total of 15,442 shares of Baxter International Inc which is valued at $668,947 after selling 1,400 shares in Baxter International Inc , the firm said in a disclosure report filed with the SEC on Apr 21, 2016.Baxter International Inc makes up approximately 0.34% of Dumont Blake Investment Advisors’s portfolio.

Baxter International Inc opened for trading at $44.34 and hit $44.78 on the upside on Wednesday, eventually ending the session at $44.18, with a gain of 0.48% or 0.21 points. The heightened volatility saw the trading volume jump to 1,19,37,938 shares. Company has a market cap of $24,205 M.

Other Hedge Funds, Including , Valley National Advisers Inc boosted its stake in BAX in the latest quarter, The investment management firm added 10 additional shares and now holds a total of 2,918 shares of Baxter International Inc which is valued at $126,408. Baxter International Inc makes up approx 0.07% of Valley National Advisers Inc’s portfolio. Boston Advisors added BAX to its portfolio by purchasing 399,091 company shares during the most recent quarter which is valued at $17,288,622. Baxter International Inc makes up approx 0.42% of Boston Advisors’s portfolio.Palisade Asset Management boosted its stake in BAX in the latest quarter, The investment management firm added 120 additional shares and now holds a total of 139,399 shares of Baxter International Inc which is valued at $5,950,943. Baxter International Inc makes up approx 1.15% of Palisade Asset Management’s portfolio.Beese Fulmer Investment Management boosted its stake in BAX in the latest quarter, The investment management firm added 2,356 additional shares and now holds a total of 43,984 shares of Baxter International Inc which is valued at $1,877,677. Baxter International Inc makes up approx 0.54% of Beese Fulmer Investment Management’s portfolio.

On the company’s financial health, Baxter International Inc reported $0.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.29. The company had revenue of $2375.00 million for the quarter, compared to analysts expectations of $2351.22 million. The company’s revenue was down -1.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Apr 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 47 from a previous price target of $40 .Baxter International Inc was Upgraded by Piper Jaffray to ” Overweight” on Apr 14, 2016. Company shares were Reiterated by RBC Capital Mkts on Feb 3, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 40 from a previous price target of $37 .

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.

Leave a Reply

Baxter International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Baxter International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.